Major Publications

Peer Reviewed Journals

1. Pernas S, Martin M, Kaufman PA, Gil-Martin M, Gomez Pardo P, Lopez-Tarruella S, Manso L, Ciruelos E, Perez-Fidalgo JA, Hernando C, Ademuyiwa FO, Weilbaecher K, Mayer I, Pluard TJ, Martinez Garcia M, Vahdat L, Perez-Garcia J, Wach A, Barker D, Fung S, Romagnoli B, Cortes J;
   Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase , single-arm, dose-escalation trial.
   Lancet Oncol. 2018 Jun;19(6):812-824. doi: 10. 1016/S1470-2045(18)30147-5. Epub 2018 Apr 26.
   
2. Bauersachs R, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler C, for the EThIG Investigators;
   Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women;
   Thromb Haemost 2007   Dec;98(6):1237-45                                    
3. Lersch C, Kotowa W, Fung S, Janssen D ; Prophylaxis of port system-associated thromboses in advanced oncology patients using heparin flushing ;
   J Cancer Res Clin Oncol. 2004 Feb 4
4. Bechtold H, Gunzenhauser D, Sawitzki H, Fung S, Janssen D ; Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion;
   Z Kardiol. 2003 Jul;92(7):532-9
5. Abramowicz D, Manas D, Lao M, Vanrenterghem Y, Del Castillo D, Wijngaard P, Fung S ; Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study;
   Transplantation 2002 Dec 27;74(12):1725-34.

Professional Activities

     UICC World Cancer Congress 2008, 2010, 2012, 2014, 2016, 2018
     Invited abstract reviewer

     Membership of several Clinical Advisory Boards

     Chair + Member of DMC's